ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Series Helps Do In Woodward As Post Metro Editor; OCC RFP Canceled, to Reappear As 4-5 RFPs

January 15, 1982

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007

ACCC Manual Tells How To Set Up, Run Cancer Program

August 27, 1976

Smoker Sues NCI To Compel Guideline For CT Scanning.

January 25, 2008

Coalition Agrees On Method To Coordinate Issues

March 21, 1980

NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate

October 22, 1993